Indefinite Delivery Contract SPE2DX15D9101

This IDV contract, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The task orders provided under this IDC cover a diverse portfolio of pharmaceutical items, such as Botox, Aspirin, Yellow Fever vaccine, contraceptives, specialty medications, and various other prescription drugs and medical supplies. These delivery orders, which do not utilize any set-aside designations, are awarded on a firm fixed-price basis and fulfilled from DMS Pharmaceutical Group's facility in Park Ridge, Illinois. The contracted products and services aim to ensure a reliable supply of critical pharmaceutical and medical items to the Department of Defense's (DoD) healthcare system, positioning DMS Pharmaceutical Group as a key supplier in the federal pharmaceutical supply chain.